DNA
Ginkgo Bioworks Holdings, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Ginkgo Bioworks Holdings, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
No other changes.
No other changes.
Last report2 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Annual filing, covered
10-K parsed · Feb 26 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Feb 26 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
−9.28%
vs ±17.3% implied · ×0.54
shaded = implied · ▲▼ = realized
Ginkgo Bioworks Holdings, Inc.
11.12
Tall tick = annual report · Source: EDGAR
Linked news
Same SIC code · 6
Same SEC industry code: Amgen Inc, Gilead Sciences, Inc., Biogen Inc. and 3 more; of Ginkgo Bioworks Holdings, Inc.'s 6 closest co-movers, none share that code.
Same SIC code · 6
Same SEC industry code: Amgen Inc, Gilead Sciences, Inc., Biogen Inc. and 3 more; of Ginkgo Bioworks Holdings, Inc.'s 6 closest co-movers, none share that code.
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $42.4M | 11.52% | +17.59% |
| Viking Global Investors | $35.4M | 9.62% | 0.00% |
| Erste | $25.9M | 7.03% | +30.25% |
| Baillie Gifford | $23.7M | 6.43% | 0.00% |
| Vanguardindex-like | $20.7M | 5.61% | +9.03% |
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $42.4M | 11.52% | +17.59% |
| Viking Global Investors | $35.4M | 9.62% | 0.00% |
| Erste | $25.9M | 7.03% | +30.25% |
| Baillie Gifford | $23.7M | 6.43% | 0.00% |
| Vanguardindex-like | $20.7M | 5.61% | +9.03% |
Bull2
Bear2
Expected move
Inputs8Q avg ±13.9%·×0.98·fair
straddle ±20.9%
spot 11.21exp Nov 20ATM strike 11ATM straddle 2.75IV 130%